contemporarypediatrics

FDA approves Avlayah for Hunter syndrome

The FDA has approved Avlayah (tividenofusp alfa-eknm) to treat the neurological manifestations of Hunter syndrome in pediatric patients. In a phase 1/2 clinical trial, the treatment led to a 91% ...
contemporarypediatrics

Balancing universal and targeted screening for type 1 diabetes

Shara Bialo, MD, explains why immunologic screening for islet autoantibodies is essential to identifying type 1 diabetes in its presymptomatic stages. In this interview with Contemporary Pediatrics, ...
contemporarypediatrics

Renuka Dias, PhD, MBBS, highlights feasibility of type 1 diabetes screening in children

Findings from the ELSA study show that population-based screening using a simple dried blood spot test is highly feasible and well accepted by families. In a Contemporary Pediatrics interview, Renuka ...
contemporarypediatrics

Accelerated aging linked to cognitive decline in young cancer survivors

AnnaLynn M. Williams, PhD; and Kevin Krull, PhD, discuss accelerated biologic aging in childhood cancer survivors. Researchers are shedding new light on how pediatric cancer survivorship affects aging ...
contemporarypediatrics

Joshua Feder, MD, discusses AACAP’s call for expanded autism treatment options

Joshua Feder, MD, explains how AACAP’s revised policy aims to improve access, insurance coverage, and family-centered decision-making for autism care. AACAP now formally supports DRBI and NDBI ...
contemporarypediatrics

FDA approves first treatment for thymidine kinase 2 deficiency

FDA approves Kygevvi, the first therapy for thymidine kinase 2 deficiency, a rare mitochondrial disease marked by muscle weakness and early death. The US Food and Drug Administration (FDA) has ...
contemporarypediatrics

Study: No short-term neurodevelopmental risk after brief anesthesia in infants

Results suggest that a single, brief exposure to general anesthesia for surgery is unlikely to impair short-term neurodevelopment in young children. Preliminary results from a randomized clinical ...
contemporarypediatrics

Full case: A newborn baby with a rash

The baby had mild respiratory distress after delivery and briefly required supplemental blow-by oxygen during transitioning. A 21-year-old primigravida woman presented to the hospital in preterm labor ...
contemporarypediatrics

Study: Potty training challenges common, with anxiety and setbacks affecting many families

Many families face common potty training challenges, including anxiety and setbacks, highlighting the need for patience and personalized strategies. A new nationally representative report from the ...
contemporarypediatrics

MNV-201 receives fast track, rare pediatric disease to treat Pearson Syndrome

MNV-201 is being evaluated in phase 2 clinical trials for treatment of the ultra-rare, life-threatening mitochondrial disorder affecting children. The FDA has granted both fast track designation and ...
contemporarypediatrics

Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD

Shorter antibiotic courses for AOM and CAP in children proved effective across a pediatric health system, according to data presented by Elysha Pifko, MD. At the 2025 Pediatric Academic Societies (PAS ...
contemporarypediatrics

FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up

The sBLA for dupilumab (Dupixent) was supported by data from the phase 3 LIBERTY-CUPID clinical program in patients with uncontrolled CSU. On April 18, 2025, the FDA approved a resubmitted ...